8262
N. A. Al-Awadi et al. / Tetrahedron 61 (2005) 8257–8263
3
.3.9. 2-(4-Chlorophenyl)-1H-benzimidazole (5d). White
7.41 (m, 2H), 7.63 (m, 2H), 7.79 (br, 1H, NH), 8.04 (m, 2H),
8.35 (m, 2H).
3
0
crystals, mp 289–290 8C (lit. 290–292 8C). LCMS: m/zZ
1
31 (MC3), 229 (MC1). H NMR (DMSO-d ): d 7.19 (m,
2
2
8
6
H), 7.57 (m, 2H), 7.58 (d, 2H, JZ8.4 Hz), 8.18 (d, 2H, JZ
.4 Hz), 12.98 (br, 1H, NH).
3.3.21. 9-Methoxyphenanthridin-6(5H)-one (8a). Color-
3
8
less crystals, mp 235 8C (lit. 235–236 8C). LCMS: m/zZ
26 (MC1).
2
3
.3.10. 2-(4-Nitrophenyl)-1H-benzimidazole (5e). White
3
2
crystals, mp 297–298 8C (lit. 297–299 8C). LCMS: m/zZ
2
8
3.3.22. 9-Methylphenanthridin-6(5H)-one (8b). LCMS:
m/zZ210 (MC1).
1
39 (MC1). H NMR (DMSO-d ): d 6.80–7.74 (m, 5H),
.25–8.57 (m, 4H).
6
3
.3.23. Phenanthridin-6(5H)-one (8c). White crystals, mp
3
9
3
(
.3.11. 4-Methoxybenzamide (6a). LCMS: m/zZ152
290–292 8C (lit. 293–294 8C). LCMS: m/zZ195 (MC1).
1
MC1). H NMR (CDCl ): d 3.45 (s, 3H, CH ), 5.88 (br
1
3
3
H NMR (DMSO-d ): d 7.26 (t, 1H, JZ7.8 Hz), 7.36 (t, 1H,
6
d, 2H, NH ), 6.93 (d, 2H, JZ8.5 Hz), 7.56 (d, 2H, JZ
JZ8.0 Hz), 7.49 (t, 1H, JZ8.0 Hz), 7.65 (t, 1H, JZ7.5 Hz),
7.84 (t, 1H, JZ8.0 Hz), 8.32 (d, 1H, JZ8.0 Hz), 8.37 (d,
2
3
1b
8
.5 Hz).
1
NH).
H, JZ8.0 Hz), 8.51 (d, 1H, JZ8.0 Hz), 11.70 (br, 1H,
3
1
.3.12. 4-Methylbenzamide (6b). LCMS: m/zZ136 (MC
1
). H NMR (CDCl ): d 2.42 (s, 3H, CH ), 5.80 (br d, 2H,
3
3
3
1c
NH ), 7.27 (d, 2H, JZ7.9 Hz), 7.73 (d, 2H, JZ7.9 Hz).
3.3.24. 9-Chlorophenanthridin-6(5H)-one (8d). White
crystals from hexane, LCMS: m/zZ232 (MC3), 230
(MC1). H NMR (CDCl ): d 7.36 (t, 1H, JZ7.8 Hz),
2
1
1
3
.3.13. Benzamide (6c). LCMS: m/zZ122 (MC1).
H
3
NMR (CDCl ): d 5.80 (br d, 2H, NH ), 7.48 (t, 2H, JZ
7.46 (d, 1H, JZ8.4 Hz), 7.60 (t, 1H, JZ8.0 Hz), 7.82 (t, 1H,
JZ7.8 Hz), 8.10 (d, 1H, JZ8.0 Hz), 8.22 (d, 1H, JZ
3
2
3
1d
7
.3 Hz), 7.57 (t, 1H, JZ7.3 Hz), 7.76 (d, 2H, JZ7.3 Hz).
4
0
8
.0 Hz), 8.41 (d, 1H, JZ8.0 Hz), 10.28 (br, 1H, NH).
3
3
7
.3.14. 4-Chlorobenzamide (6d). LCMS: m/zZ158 (MC
1
), 156 (MC1). H NMR (CDCl ): d 5.90 (br d, 2H, NH ),
3
2
3.3.25. 9-Nitrophenanthridin-6(5H)-one (8e). LCMS:
3
3
1
.45 (d, 2H, JZ8.3 Hz), 7.78 (d, 2H, JZ8.5 Hz).
m/zZ241 (MC1). H NMR (CDCl ): d 7.36 (t, 1H, JZ
3
7
.8 Hz), 7.46 (m, 1H), 7.64 (m, 1H), 7.78 (t, 1H, JZ7.8 Hz),
3
.3.15. 4-Nitrobenzamide (6e). LCMS: m/zZ167 (MC1).
7.95 (d, 1H, JZ8.0 Hz), 8.38 (d, 1H, JZ8.0 Hz), 8.51 (d,
1H, JZ8.0 Hz), 10.25 (br, 1H, NH).
1
40
H NMR (CDCl ): d 5.72, 6.11 (br d, 2H, NH ), 8.0 (d, 2H,
JZ8.4 Hz), 8.34 (d, 2H, JZ7.4 Hz).
3
2
3
1e
C
.3.26. Cyanocyclopentadiene (9). MS: m/zZ91 (M ,
3
10%), H NMR (CDCl ): d 3.26 (m, 2H), 6.65 (m, 2H), 7.25
(m, 1H).
1
3.3.16. 4-Methoxy-N-phenylbenzamide (7a). White
crystals, mp 170–171 8C (lit. 169–170 8C). LCMS:
m/zZ228 (MC1). H NMR (CDCl ): d 3.88 (s, 3H), 6.68
3
3
4
41
1
3
(
d, 2H, JZ8.6 Hz), 7.15 (t, 1H, JZ7.8 Hz), 7.43 (t, 2H, JZ
3.4. Kinetic runs and data analysis
8
.0 Hz), 7.58 (d, 2H, JZ7.6 Hz), 7.82 (d, 2H, JZ8.6 Hz),
7
.89 (br, 1H, NH).
Stock solution (7 mL) is prepared by dissolving 6–10 mg of
the substrate in acetonitrile as solvent to give a concen-
tration of 1000–2000 ppm. Internal standard is then added,
the amount of, which is adjusted to give the desired peak
area ratio of substrate to standard (2.5:1). The solvent and
the internal standard are selected because both are stable
under the conditions of pyrolysis, and because they do not
react with either substrate or product. The internal standard
used in this study, is chlorobenzene. Each solution is filtered
to ensure that a homogeneous solution is obtained.
3
.3.17. 4-Methyl-N-phenylbenzamide (7b). White
3
4
crystals, mp 149–150 8C (lit. 150 8C). LCMS: m/zZ212
1
(
MC1). H NMR (CDCl ): d 2.44 (s, 3H), 7.17 (t, 1H, JZ
3
7.3 Hz), 7.29 (d, 2H, JZ8.0 Hz), 7.39 (t, 2H, JZ8.0 Hz),
7.66 (d, 2H, JZ7.8 Hz), 7.79 (d, 2H, JZ8.0 Hz), 7.88 (br,
1H, NH).
3
1
.3.18. N-Phenylbenzamide (7c). White crystals, mp 159–
3
5
1
60 8C (lit. 159–161 8C). LCMS: m/zZ198 (MC1). H
NMR (CDCl ): d 7.11 (t, 1H, JZ7.3 Hz), 7.36 (t, 2H, JZ
The weight ratio of the substrate with respect to the internal
standard is calculated from the ratio of the substrate peak
area to the peak area of the internal standard. The kinetic
rate was obtained by tracing the rate of disappearance of the
substrate with respect to the internal standard as follows:
3
7.6 Hz), 7.53 (t, 2H, JZ7.0 Hz), 7.60 (t, 1H, JZ7.2 Hz),
7.80 (d, 2H, JZ8.2 Hz), 7.97 (d, 2H, JZ7.4 Hz), 10.3 (br,
1H, NH).
3
.3.19. 4-Chloro-N-phenylbenzamide (7d). Colorless
crystals, mp 195–196 8C (lit. 195–196 8C). LCMS:
3
6
An aliquot part (0.2 mL) of each solution containing the
substrate and the internal standard is pipetted into the
reaction tube, which is then placed in the pyrolyzer for
6 min under non-thermal conditions. A sample is then
analyzed using the HPLC probe with the UV detector at
1
m/zZ234 (MC3), 232 (MC1). H NMR (DMSO-d ): d
6
7
.12 (t, 1H, JZ7.3 Hz), 7.34 (t, 2H, JZ7.8 Hz), 7.60 (d, 2H,
JZ8.4 Hz), 7.75 (d, 2H, JZ8.0 Hz), 7.98 (d, 2H, JZ
8
.4 Hz), 10.30 (br, 1H, NH).
wavelength of 256 nm, and the standardization value (A ) is
o
3.3.20. 4-Nitro-N-phenylbenzamide (7e). Colorless
crystals, mp 217–218 8C (lit. 217–218.5 8C). LCMS:
then calculated. Several HPLC measurements are obtained
with an accuracy of R2%. The temperature of the pyrolysis
block is then raised until approximately 10% pyrolysis is
3
7
1
m/zZ244 (MC1). H NMR (CDCl ): d 7.21 (m, 1H),
3